| Hepatology - Clinical trial aims to provide a surgical solution for patients with 'inoperable' pancreatic tumors |
|
|
|
|
| |
|
|
| |
The latest hepatology news from News Medical |
|
|
|
 | | |
 Breath biomarkers: detecting liver disease early
Liver disease causes around 2 million deaths worldwide annually, but 9/10 cases could be prevented. Breath is enriched with compounds that are associated with liver disease, meaning these compounds could act as biomarkers. This document details the potential of breath and its potential use in liver disease research to develop better diagnostic and monitoring tools.
| |
|
|
|
|
| | |  Fibrolamellar carcinoma (FLC) is a rare liver cancer with a poor prognosis if not addressed early with surgery. The disease is caused by a single genetic mutation that creates a fusion protein. | | | | |  Portal hypertension (PHT) is a severe complication of chronic liver disease, like cirrhosis, where increased pressure builds up in the portal vein. | | | | |  The Department of Clinical Medicine at the Miguel Hernández University of Elche (UMH) leads research on the immune system's role in advanced chronic liver disease. | | | | |  Research led by Amsterdam UMC across ten Dutch hospitals and two Italian hospitals has found that not placing a drain during surgery improves outcomes in patients undergoing a left-sided pancreatic resection, also known as 'distal pancreatectomy'. | | | | |  Adding a personalized anti-tumor vaccine to standard immunotherapy is safe and about twice as likely to shrink cancer as standard immunotherapy alone for patients with hepatocellular carcinoma, the most common type of liver cancer, according to a clinical trial led by researchers at the Johns Hopkins Kimmel Cancer Center and its Convergence Institute. | |
|
|
|
|
| | | How would you rate today's newsletter?
| |
|
|
|
|
|
